Not known Details About top pharma blogs
January 21, 2025 In 21 CFR 211.94 it is mentioned that “Drug products containers and closures shall not be reactive, additive, or absorptive to alter the safety, id, power, top quality or purity on the drug further than the official or proven specifications.” Even though the code makes this statement, and if expanded on within the related FDA D